Iovance Biotherapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Iovance Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iovance Biotherapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iovance Biotherapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $985k | 121k | 8.13 |
| 2023-09-30 | $551k | 121k | 4.55 |
| 2023-06-30 | $772k | 110k | 7.04 |
| 2022-12-31 | $502k | 79k | 6.39 |
| 2022-09-30 | $753k | 79k | 9.58 |
| 2022-06-30 | $867k | 79k | 11.03 |
| 2022-03-31 | $83k | 5.0k | 16.58 |
| 2021-09-30 | $50k | 2.0k | 24.53 |
| 2020-03-31 | $1.5M | 49k | 29.94 |
| 2019-12-31 | $1.4M | 52k | 27.68 |
| 2019-09-30 | $939k | 52k | 18.20 |
| 2019-06-30 | $1.2M | 48k | 24.53 |
| 2019-03-31 | $459k | 48k | 9.50 |
| 2018-12-31 | $428k | 48k | 8.86 |
| 2018-09-30 | $677k | 60k | 11.26 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors